Xerogenic medications may contribute to decreased unstimulated salivary flow in patients with oral burning and/or gastro-esophageal reflux disease.

Last, although an interesting trend was seen between UWSFR and type of medication, some of the findings are based on small sample size (e.g., medication use) and should be interpreted with caution until larger studies are performed. 5.

also in 809 other papers